Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

72.18
-0.7800-1.07%
Post-market: 72.180.00000.00%19:30 EDT
Volume:309.51K
Turnover:22.34M
Market Cap:1.66B
PE:15.90
High:73.27
Open:73.16
Low:71.73
Close:72.96
52wk High:97.00
52wk Low:69.58
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.89
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.78
PE(LYR):21.74

Loading ...

ANI Pharma SVP, CFO Stephen P. Carey Sells USD 208,050 in Common Shares

Reuters
·
Oct 01

ANI Pharmaceuticals to Present Phase 4 Synchronicity Trial Data on Fluocinolone Acetonide Intravitreal Implant at AAO 2026 Meeting

Reuters
·
Sep 30

ANI Pharmaceuticals Price Target Announced at $85.00/Share by Oppenheimer

Dow Jones
·
Sep 23

ANI Pharmaceuticals Wins FDA Approval for Generic Everolimus Tablets

MT Newswires Live
·
Sep 23

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

THOMSON REUTERS
·
Sep 23

Oppenheimer Initiates ANI Pharmaceuticals at Perform With $85 Price Target

MT Newswires Live
·
Sep 23

H.C. Wainwright Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Sep 22

ANI Pharma CEO Nikhil Lalwani Disposes of 5,400 Common Shares Worth $383,400

Reuters
·
Sep 17

ANI Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

ANI Pharma SVP, CFO Stephen P. Carey Sells 2,850 Shares for $207,480

Reuters
·
Sep 02

ANI Pharmaceuticals Director Henry O. Gosebruch Files Initial Beneficial Ownership Statement (Form 3)

Reuters
·
Aug 28

How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition

Simply Wall St.
·
Aug 27

ANI Pharma CEO Nikhil Lalwani Disposes of 5,400 Common Shares Worth $401,220

Reuters
·
Aug 27

ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays

TIPRANKS
·
Aug 26

ANI Pharmaceuticals reshapes board to advance rare disease strategy

TIPRANKS
·
Aug 24

A Quiet Monday: What Wall Street Didn't File

FilingAlpha
·
Aug 24

ANI Pharma Appoints Henry Gosebruch to Board of Directors

Reuters
·
Aug 24

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

THOMSON REUTERS
·
Aug 24

ANI Pharma General Counsel Meredith Cook Sells 500 Shares for $37,740

Reuters
·
Aug 14